InsiderTrades.com logo
Move Your Money Before May 1
From Stansberry Research   |   Ad
Did you know that the IRS has allegedly been using AI to spy on the bank accounts of American citizens?
Click here to get the full story before May 1. 

CMRA Insider Trading

Insider Ownership Percentage: 8.90%
Insider Buying (Last 12 Months): $1,199,689.77
Insider Selling (Last 12 Months): $0.00

Comera Life Sciences Insider Trading History Chart

This chart shows the insider buying and selling history at Comera Life Sciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Comera Life Sciences Share Price & Price History

Current Price: $0.04
Price Change: ▼ Price Decrease of -0.0049 (-11.95%)
As of 04/26/2024 02:18 PM ET

This chart shows the closing price history over time for CMRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

Comera Life Sciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/11/2023Charles CheringtonMajor ShareholderBuy2,053,789$0.51$1,047,432.395,813,650View SEC Filing Icon  
8/14/2023Robert Patrick MahoneyInsiderBuy20,000$0.63$12,600.00124,576View SEC Filing Icon  
7/31/2023David SoaneMajor ShareholderBuy273,838$0.51$139,657.38225,648View SEC Filing Icon  
1/4/2023David SoaneMajor ShareholderBuy202,701$1.23$249,322.233,336,562View SEC Filing Icon  
11/8/2022David SoaneMajor ShareholderBuy3,000$1.38$4,140.003,268,995View SEC Filing Icon  
10/20/2022Charles CheringtonMajor ShareholderBuy3,316$1.52$5,040.32638,246View SEC Filing Icon  
10/17/2022Charles CheringtonMajor ShareholderBuy15,266$1.66$25,341.56634,930View SEC Filing Icon  
10/13/2022Charles CheringtonMajor ShareholderBuy10,481$1.66$17,398.46615,411View SEC Filing Icon  
9/29/2022Charles CheringtonMajor ShareholderBuy17,900$1.87$33,473.00604,930View SEC Filing Icon  
9/27/2022Charles CheringtonMajor ShareholderBuy12,000$1.69$20,280.00587,030View SEC Filing Icon  
9/12/2022James SherblomDirectorBuy50,000$2.03$101,500.00371,163View SEC Filing Icon  
9/9/2022Jeffrey S HackmanInsiderBuy47,600$2.06$98,056.0047,600View SEC Filing Icon  
9/8/2022Michael Gerard CampbellCFOBuy25,000$2.07$51,750.0025,000View SEC Filing Icon  
See Full Table
Protect Yourself While There’s Still Time …
From Weiss Ratings   |   Ad
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

SEC Filings (Institutional Ownership Changes) for Comera Life Sciences (NASDAQ:CMRA)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CMRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Comera Life Sciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/15/2022Lake Street Advisors Group LLC316,469$0.51M0.0%+216.5%2.390%Search for SEC Filing on Google Icon
11/14/2022Bluefin Capital Management LLC19,584$32K0.0%-28.8%0.148%Search for SEC Filing on Google Icon
11/7/2022Virtu Financial LLC15,354$25K0.0%N/A0.116%Search for SEC Filing on Google Icon
11/2/2022Arena Investors LP84,944$0.14M0.1%N/A0.642%Search for SEC Filing on Google Icon
8/15/2022Bluefin Capital Management LLC27,511$73K0.0%N/A0.208%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Comera Life Sciences logo
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
Read More on Comera Life Sciences

Today's Range

Now: $0.04
Low: $0.04
High: $0.04

50 Day Range

MA: $0.04
Low: $0.03
High: $0.06

52 Week Range

Now: $0.04
Low: $0.02
High: $0.83

Volume

267 shs

Average Volume

21,568 shs

Market Capitalization

$1.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.37

Who are the company insiders with the largest holdings of Comera Life Sciences?

Comera Life Sciences' top insider investors include:
  1. Charles Cherington (Major Shareholder)
  2. David Soane (Major Shareholder)
  3. James Sherblom (Director)
  4. Robert Patrick Mahoney (Insider)
  5. Jeffrey S Hackman (Insider)
  6. Michael Gerard Campbell (CFO)
Learn More about top insider investors at Comera Life Sciences.
The Next Step of Their Control Is Here …
From Weiss Ratings   |   Ad
Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.
4 simple steps to protect your privacy and money before it’s too late.